SpringWorks Therapeutics (SWTX) Financials

$46.99

$0.00 (0.00%)

As on 02-Jul-2025 09:30EDT

Market cap

$3,541 Mln

Revenue (TTM)

$220 Mln

P/E Ratio

--

P/B Ratio

8.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Operating Revenue	219.67	191.59	5.45	6.15	35.00	35.00
Cost of Revenue	14.88	12.55	0.42	1.90	0.49	0.35
Gross Profit	204.80	179.04	5.03	6.15	-0.49	34.65
Operating Expenses	469.53	457.17	348.04	280.67	173.47	81.32
Operating Profit (EBIT)	-264.74	-278.13	-343.01	-280.67	-173.47	-46.32
Other Income	--	--	--	--	--	--
Profit before Tax	-253.93	-258.13	-325.10	-277.42	-173.91	-45.57
Provision for Tax	--	--	-22.95	-3.26	-0.70	-1.33
Profit after Tax (Net Income)	-253.93	-258.13	-325.10	-274.16	-173.21	-44.24
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-277.42	-173.91	-45.57

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Shareholder's Funds	417.40	481.10	626.22	-569.93	422.40	557.06
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.69	6.18	21.40	21.00	0.13	1.52
Current Liabilities	82.27	99.99	78.17	51.05	29.97	17.61
Total Liabilities	587.62	587.28	725.79	630.24	452.49	576.19

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Non-Current Assets	149.04	206.81	224.88	30.48	69.58	62.79
Current Assets	356.32	380.47	500.91	599.76	382.91	513.40
Total Assets	587.62	587.28	725.79	-497.88	452.49	576.19
Total Debt*	7.39	7.91	7.06	5.25	1.29	2.73
Net Current Assets	274.05	280.48	422.74	548.71	352.94	495.79

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Cash From Operating Activities	--	-175.60	-222.80	-161.56	-127.88	-32.19
Cash Flow from Investing Activities	--	64.55	34.75	-215.60	83.59	-418.83
Cash from Financing Activities	--	4.76	296.64	340.70	1.16	270.49
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Adjusted EPS ($)	-3.41	-3.48	-4.42	-4.39	-3.55	-0.94
Cash EPS ($)	--	-3.44	-4.41	-4.38	-3.54	-0.93
Adjusted Book Value ($)	--	6.49	8.52	--	8.67	11.77
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.37	-3.03	-2.59	-2.62	-0.68
Free Cash Flow per Share ($)	--	-2.43	-3.13	-2.75	-2.67	-0.69

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
ROCE (%)	--	-46.00	-947.87	388.90	-35.22	-10.03
ROE (%)	-53.46	-46.62	-1,155.12	371.66	-35.37	-10.07
ROA (%)	-38.67	-39.32	-47.95	-50.64	-33.68	-9.71
EBIT Margin (%)	-120.52	-145.17	-6,297.28	-4,566.03	-495.62	-132.35
Net Margin (%)	-115.60	-134.73	-5,968.50	-4,460.06	-494.89	-126.41
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Revenue Growth (%)	480.11	34.17	-0.11	-0.82	--	--
EBIT Growth (%)	26.49	18.92	-22.21	-61.80	-274.47	21.80
Net Profit Growth (%)	25.11	20.60	-18.58	-58.28	-291.49	19.20
EPS Growth (%)	31.55	0.21	-0.01	-0.24	-2.80	0.27
Book Value Growth (%)	-27.54	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Price / Earnings	--	-10.38	-8.25	-5.92	-17.44	-77.55
Price / Book Value	8.48	5.57	4.28	-2.85	7.15	6.16
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-7.90	-8.55	-6.47	-3.70	-15.31	-63.63
Close Price ($)	44.13	36.13	36.50	26.01	61.98	72.52
High Price ($)	62.00	53.92	38.31	66.12	96.48	80.31
Low Price ($)	28.21	28.21	18.00	13.60	51.72	19.50
Market Cap ($ Cr)	3,540.65	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Debt to Equity	--	0.02	0.01	-0.01	0.00	0.00
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.01	0.00
Current Ratio	4.33	3.81	6.41	11.75	12.78	29.15
Quick Ratio	4.18	3.70	6.37	11.75	--	--
Interest Coverage	-253.44	--	--	-366.89	-392.46	--

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-10	Dec-09
Debtors to sales (%)	18.37	24.13	108.87	--	--	--
Asset Turnover	0.33	0.29	0.01	0.01	0.07	0.08
Receivable days	--	49.73	198.82	--	--	--
Inventory Days	--	193.76	1,342.86	--	--	--
Payable days	--	285.86	6,667.11	1,101.82	1,781.15	2,095.22
Cash Conversion Cycle	--	-42.37	-5,125.44	-1,101.82	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.